HHS

US govt addressing Medicare payments for biosimilars
US govt addressing Medicare payments for biosimilars
Pharma Letter
HHS
Medicare
biosimilars
Medicare Part B
Inflation Reduction Act
CMS
Flag link:
HHS to pay for 60K doses of Eli Lilly's COVID-19 drug following its commercialization
HHS to pay for 60K doses of Eli Lilly's COVID-19 drug following its commercialization
Beckers Hospital Review
Eli Lilly
COVID-19
bebtelovimab
federal contracts
HHS
Flag link:
Patient groups sue feds to crack down on insurer, PBM copay adjustment programs
Patient groups sue feds to crack down on insurer, PBM copay adjustment programs
Fierce Healthcare
PBMs
copay asssistance programs
drug pricing
HHS
Flag link:
HHS to distribute 1.6M monkeypox vaccine doses this year
HHS to distribute 1.6M monkeypox vaccine doses this year
Endpoints
monkeypox
HHS
vaccines
Bavarian Nordic
Flag link:
Medicare premiums to remain unchanged after Aduhelm price cut spurs review
Medicare premiums to remain unchanged after Aduhelm price cut spurs review
BioPharma Dive
Medicare
Medicare Part B
Biogen
Aduhelm
HHS
Alzheimer's disease
Flag link:
US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf
US sees spike in Paxlovid usage as Merck's molnupiravir and AstraZeneca's Evusheld are slower off the shelf
Endpoints
Pfizer
HHS
Paxlovid
Merck
molnupiravir
AstraZeneca
Evusheld
COVID-19
Flag link:
'March-in' battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision
'March-in' battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision
Endpoints
HHS
Bayh-Dole Act
drug pricing
Pfizer
Gilead Sciences
Xtandi
Paxlovid
Epclusa
Descovy
insulin
Flag link:
AstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to $855M
AstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to $855M
Fierce Pharma
AstraZeneca
COVID-19
Evushield
HHS
Flag link:
Doctor groups urge Biden administration to disclose costs of federally funded clinical trials
Doctor groups urge Biden administration to disclose costs of federally funded clinical trials
Fierce Biotech
Joe Biden
physicians
clinical trials
BARDA
FDA
HHS
Flag link:
FDA Is Back in the Driver’s Seat with LDTs
FDA Is Back in the Driver’s Seat with LDTs
Medical Devices and Diagnostics Industry
FDA
HHS
COVID-19
diagnostics
LDTs
Flag link:
Judge rules HHS' letter enforcing 340B discounts was 'arbitrary'
Judge rules HHS' letter enforcing 340B discounts was 'arbitrary'
Beckers Hospital Review
HHS
drug pricing
340B
AstraZeneca
Eli Lilly
Novo Nordisk
Sanofi
United Therapeutics
Flag link:
Eli Lilly serves up a win over Biden's HHS in drug discount court case
Eli Lilly serves up a win over Biden's HHS in drug discount court case
Endpoints
Eli Lilly
Indiana
HHS
Joe Biden
drug discounts
Flag link:
HHS lines up Novartis, Lilly, AstraZeneca and 3 other drugmakers for fines due to drug discount violations
HHS lines up Novartis, Lilly, AstraZeneca and 3 other drugmakers for fines due to drug discount violations
Endpoints
HHS
340B
discounts
Novartis
Eli Lilly
AstraZeneca
Novo Nordisk
Sanofi
United Therapeutics
Flag link:
HHS cites real-world data for Covid-19 boosters; WHO says the science is still out
HHS cites real-world data for Covid-19 boosters; WHO says the science is still out
MedCity News
COVID-19
vaccines
boosters
Delta COVID-19 variant
WHO
HHS
Flag link:
CMS proposes to Withdraw Trump Era Most Favored Nation (MFN) Drug Pricing Rule
CMS proposes to Withdraw Trump Era Most Favored Nation (MFN) Drug Pricing Rule
FDA Law Blog
HHS
Donald Trump
Medicare
Medicare Part B
most favored nation
drug pricing
Flag link:
HHS withdraws Trump-era plan to allow more personal drug, insulin imports
HHS withdraws Trump-era plan to allow more personal drug, insulin imports
Endpoints
Joe Biden
Donald Trump
HHS
insulin
drug importation
Flag link:
Under ‘threat’ of fines, Novartis sues HHS over drug pricing program
Under ‘threat’ of fines, Novartis sues HHS over drug pricing program
Endpoints
Novartis
HHS
drug pricing
Flag link:
Letting HHS negotiate drug prices could save businesses $195B, analysis finds
Letting HHS negotiate drug prices could save businesses $195B, analysis finds
Beckers Hospital Review
HHS
drug prices
Flag link:
Eli Lilly sues HHS to halt any 340B-related monetary penalties
Eli Lilly sues HHS to halt any 340B-related monetary penalties
Endpoints
HHS
340B
Eli Lilly
Flag link:
HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access
HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access
Stat
Moderna Therapeutics
vaccines
COVID-19
patents
HHS
Flag link:

Pages